[Form 4] Wrap Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Wrap Technologies, Inc. (WRAP) – Form 4 insider transaction

Director Timothy Szymanski reported receiving 19,391 Restricted Stock Units (RSUs) on 01 Jul 2025 for board service covering the quarter ended 30 Jun 2025. The award carries a grant price of $0 because RSUs are equity-settled compensation; 12,604 units vested immediately on the grant date, with the remaining shares vesting in eight equal monthly tranches. After the grant, Szymanski’s direct beneficial ownership rose to 110,566 common shares. No derivative securities were involved and there were no open-market purchases or sales.

The filing represents a routine director compensation grant, resulting in only marginal dilution to existing shareholders and aligning the director’s incentives with long-term equity performance. No financial performance data or earnings information was disclosed in this filing.

Positive

• Aligns director incentives with shareholder value through equity-based compensation
• Dilution impact is immaterial at roughly 0.04% of shares outstanding

Negative

• Increases share count, albeit minimally, through issuance of new RSUs

Insights

Securities Analyst

TL;DR – Routine RSU grant; neutral impact, minimal dilution, improves director alignment.

The 19,391-share RSU award to Director Timothy Szymanski is standard board compensation and does not signal any material change in corporate outlook or insider sentiment. Because the award vests over eight months and was issued at no cash cost, dilution is de minimis relative to WRAP’s 47 million basic shares outstanding (≈0.04%). The absence of open-market buying or selling indicates the transaction is purely service-related, keeping the director’s interests aligned with shareholders without implying bullish or bearish positioning. Overall market impact is expected to be negligible.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Szymanski Timothy

(Last) (First) (Middle)

C/O WRAP TECHNOLOGIES, INC.

3480 MAIN HWY, SUITE 202

(Street)

MIAMI FL 33133

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WRAP TECHNOLOGIES, INC. [ WRAP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		A		19,391	A	$0(1)	110,566	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2025. On the date of grant, 12,604 of the RSUs vested and the remainder of the RSUs vest ratably in eight monthly tranches.

	/s/ Timothy Szymanski	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many WRAP shares did Director Timothy Szymanski receive?

He was granted 19,391 RSUs, with 12,604 vesting immediately and the rest monthly.

What is the cost basis of the RSUs granted on 01-Jul-2025?

The RSUs were issued at $0 as equity compensation; no cash was exchanged.

How many WRAP shares does the director own after the transaction?

Following the grant, Szymanski beneficially owns 110,566 common shares.

Does this Form 4 indicate insider buying or selling?

No. It reflects a routine director RSU grant; there were no open-market purchases or sales.

Will the transaction materially dilute existing WRAP shareholders?

Dilution is minimal (≈0.04%) relative to the company’s share count and is unlikely to impact valuation.